Horizon Therapeutics Common
|
15.0 |
$843M |
|
9.0M |
93.64 |
Mirati Therapeutics Common
|
14.4 |
$808M |
|
5.0M |
161.53 |
United Therapeutics Corp Common
(UTHR)
|
9.6 |
$538M |
|
3.0M |
179.41 |
Acceleron Pharma Common
|
6.7 |
$377M |
|
3.0M |
125.49 |
Argenx Se Sponsored ADR
(ARGX)
|
5.1 |
$285M |
|
947k |
301.07 |
Arena Pharmaceuticals Common
|
5.0 |
$278M |
|
4.1M |
68.20 |
Ascendis Pharma Sponsored ADR
(ASND)
|
4.5 |
$250M |
|
1.9M |
131.55 |
Iovance Biotherapeutics Common
(IOVA)
|
4.2 |
$237M |
|
9.1M |
26.02 |
Sarepta Therapeutics Common
(SRPT)
|
3.3 |
$187M |
|
2.4M |
77.74 |
Vertex Pharmaceuticals Common
(VRTX)
|
2.8 |
$159M |
|
790k |
201.63 |
Madrigal Pharmaceuticals Common
(MDGL)
|
2.5 |
$139M |
|
1.4M |
97.41 |
Biomarin Pharmaceutical Common
(BMRN)
|
2.5 |
$138M |
|
1.7M |
83.44 |
Amicus Therapeutics Common
(FOLD)
|
2.1 |
$120M |
|
13M |
9.64 |
Constellation Pharmaceuticals Common
|
1.9 |
$109M |
|
3.2M |
33.80 |
Mersana Therapeutics Common
(MRSN)
|
1.6 |
$92M |
|
6.8M |
13.58 |
Kura Oncology Common
(KURA)
|
1.5 |
$86M |
|
4.1M |
20.85 |
Apellis Pharmaceuticals Common
(APLS)
|
1.4 |
$79M |
|
1.2M |
63.20 |
Xenon Pharmaceuticals Common
(XENE)
|
1.2 |
$68M |
|
3.7M |
18.62 |
Pmv Pharmaceuticals Common
(PMVP)
|
1.1 |
$62M |
|
1.8M |
34.16 |
Monte Rosa Therapeutics Common
(GLUE)
|
1.1 |
$62M |
|
3.3M |
18.77 |
Acadia Pharmaceuticals Common
(ACAD)
|
1.1 |
$60M |
|
2.4M |
24.39 |
Marinus Pharmaceuticals Common
(MRNS)
|
1.0 |
$58M |
|
3.2M |
17.94 |
Trillium Therapeutics Common
|
1.0 |
$55M |
|
5.7M |
9.70 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.9 |
$52M |
|
3.0M |
17.17 |
Mannkind Corp Common
(MNKD)
|
0.8 |
$47M |
|
8.6M |
5.45 |
Cymabay Therapeutics Common
|
0.8 |
$45M |
|
10M |
4.36 |
Iveric Bio Common
|
0.7 |
$41M |
|
6.4M |
6.31 |
Deciphera Pharmaceuticals Common
|
0.7 |
$39M |
|
1.1M |
36.61 |
Relmada Therapeutics Common
(RLMD)
|
0.5 |
$30M |
|
935k |
32.01 |
Avadel Pharmaceuticals Sponsored ADR
|
0.5 |
$29M |
|
4.4M |
6.73 |
Praxis Precision Medicines Common
|
0.5 |
$29M |
|
1.6M |
18.28 |
Design Therapeutics Common
(DSGN)
|
0.5 |
$26M |
|
1.5M |
17.99 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.5 |
$26M |
|
6.0M |
4.38 |
Olema Pharmaceuticals Common
(OLMA)
|
0.4 |
$25M |
|
877k |
27.98 |
Adverum Biotechnologies Common
|
0.4 |
$24M |
|
7.0M |
3.50 |
Merus N V Common
(MRUS)
|
0.2 |
$14M |
|
660k |
21.07 |
Avidity Biosciences Common
(RNA)
|
0.2 |
$14M |
|
545k |
24.71 |
Fennec Pharmaceuticals Common
(FENC)
|
0.2 |
$12M |
|
1.7M |
7.29 |
Genocea Biosciences Common
(GNCAQ)
|
0.2 |
$12M |
|
5.1M |
2.34 |
Centessa Pharmaceuticals Sponsored ADS
(CNTA)
|
0.2 |
$11M |
|
500k |
22.21 |
Alnylam Pharmaceuticals Common Call Option
(ALNY)
|
0.2 |
$11M |
|
1.2M |
9.50 |
Bctg Acquisition Corp Common
|
0.2 |
$9.1M |
|
800k |
11.37 |
Adaptimmune Therapeutics Sponsored ADR
(ADAP)
|
0.2 |
$8.6M |
|
2.0M |
4.26 |
Aerpio Pharmaceuticals Common
|
0.1 |
$7.6M |
|
4.5M |
1.69 |